GlassScriptPhysician profile
Logan E Mast
NPI 1790928505
$23,870.81
in general payments reported to CMS, 2019-2025
28 companies · $2,900 in 2025
The $2,900 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $4,324 · 2021: $511 · 2022: $3,502 · 2023: $727 · 2024: $359 · 2025: $2,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,292 · Travel and Lodging: $1,244 · Education: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,291.73 |
| Travel and Lodging | $1,244.13 |
| Education | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $7,854.68 | 2019-2024 | |
| Arthrex, INC. | $5,042.00 | 2019-2025 | Knee & Hip Implants Meniscal Repair Fiberstitch |
| Depuy Synthes Products, INC. | $3,487.50 | 2019-2022 | |
| Stryker Corporation | $2,589.82 | 2019-2024 | Mako, Biosteon |
| Blue Surgical LLC | $1,603.98 | 2024-2025 | |
| Smith+Nephew, INC. | $615.91 | 2019-2024 | Stravix, Evos |
| Depuy Synthes Sales INC. | $540.99 | 2019-2025 | Truespan Orthocord, Healix Knotless Peek, Dynacord |
| Horizon Therapeutics Plc | $422.11 | 2019-2022 | |
| Pacira Therapeutics, INC. | $325.15 | 2019-2020 | |
| Medical Device Business Services, INC. | $292.45 | 2019-2022 | |
| Bioventus LLC | $237.93 | 2019-2025 | Xcell, Exogen Ultrasound Bone Healing System, Durolane |
| Zimmer Biomet Holdings, INC. | $168.59 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $167.09 | 2019-2025 | Euflexxa |
| Medacta USA, INC. | $82.68 | 2025 | Mecta |
| Vertex Pharmaceuticals Incorporated | $68.72 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $60.16 | 2019 | |
| Ermi LLC | $55.20 | 2019-2023 | |
| Medtronic, INC. | $41.86 | 2024-2025 | Aquamantys(Tm), Synchromedii |
| Anika Therapeutics, INC. | $31.82 | 2025 | Integrity Implant |
| Xiros INC | $30.90 | 2023 | N/A |
| Sanofi-Aventis U.S. LLC | $27.42 | 2019-2020 | |
| Solventum Corporation | $22.11 | 2025 | V.A.C. Veraflo, Prevena |
| Polynovo North America LLC | $21.37 | 2025 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $19.37 | 2022 | |
| Amgen INC. | $17.87 | 2024 | Evenity, Prolia |
| Orthofix Medical, INC. | $17.48 | 2022 | |
| Vericel Corporation | $14.32 | 2023 | Maci |
| Zyla Life Sciences, INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Mast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.